title: Registration of Observational Studies: perspectives from an industry-based epidemiology group.
abstract: Registration of randomized clinical trials has become standard practice and is enforced through publication policies and governmental regulations. However, the registration of observational studies remains controversial. In this commentary, we propose that a compromise can be reached on which observation should be registered based on study design and study intent.
authors.affiliation: Johnson & Johnson Pharmaceutical Research and Development, Titusville, NJ, USA. schavers@its.jnj.com
authors.forename: Scott
authors.initials: S
authors.lastname: Chavers
authors.forename: Daniel
authors.initials: D
authors.lastname: Fife
authors.forename: Mary
authors.initials: M
authors.lastname: Wacholtz
authors.forename: Paul
authors.initials: P
authors.lastname: Stang
authors.forename: Jesse
authors.initials: J
authors.lastname: Berlin
mesh_terms: D004345:Drug Industry / Q000941:ethics / Q000331:legislation & jurisprudence* / Q000592:standards*; D016021:Epidemiologic Studies; D006801:Humans; D019370:Observation; D016032:Randomized Controlled Trials as Topic; D012107:Research Design